Results 181 to 190 of about 14,827 (208)

Therapeutic Efficacy of Apomorphine Combined With an Extracerebral Inhibitor of Dopamine Receptors in Parkinson's Disease.

Lancet, The, 1979
Maria Del Zompo, Giovanni U Corsini, G L Gessa   +2 more
exaly  

Role of Subcutaneous Apomorphine in Parkinsonian Voiding Dysfunction.

Lancet, The, 1988
Andrew John Lees, Christopher R Chapple, G M Stern   +2 more
exaly  

Expert Consensus Group Report on the Use of Apomorphine in the Treatment of Parkinson's Disease – Clinical Practice Recommendations

Parkinsonism and Related Disorders, 2015
Teus van Laar, Andrew H Evans, Pedro J Garcia Ruiz   +2 more
exaly  

Apomorphine

Reactions Weekly, 1990
openaire   +2 more sources

Apomorphine as a Discriminative Stimulus, and Its Antagonism by Haloperidol

European Journal of Pharmacology, 1975
Paul A J Janssen, Francis C Colpaert, Carlos J E Niemegeers   +2 more
exaly  

O-Methylation of Apomorphine and the Metabolic Prolongation of Apomorphine-Induced Stereotyped Behaviour

European Journal of Pharmacology, 1973
Samarthji Lal, S Lal, Theodore L Sourkes
exaly  

Apomorphine

BMJ, 1962
openaire   +1 more source

Apomorphine: An Underutilized Therapy for Parkinson's Disease

Movement Disorders, 2000
Gregor Wenning, Werner Poewe
exaly  

SUBLINGUAL APOMORPHINE

2010
GIOVINAZZO ANTHONY JOHN, HEDDEN DAVID BRUCE, DE SOMER MARC L, BRYSON NATHAN JOHN   +3 more
openaire   +14 more sources

Apomorphine Monotherapy in the Treatment of Refractory Motor Complications of Parkinson's Disease: Long-Term Follow-Up Study of 64 Patients

Movement Disorders, 2002
Andrew John Lees
exaly